You are here

Articles

Combating Progressive Disease by Monitoring and Early Detection: War and PCR

published: 9 November 2008

Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanis

published: 7 November 2008

3rd Generation Inhibitors in Development-AP24534, VX-680 (MK-0457), PHA-739358, PPY-A, XL-228, SGX-70393, FTY720 and TG101113

published: 30 October 2008

Newly Diagnosed? Would you like to participate in a Clinical Research Study of a new treatment for CML?

published: 24 October 2008

M. D. Anderson - Leukemia Insights Newsletter Volume 13, No. 2 Fall 2008

published: 10 October 2008

Bone-marrow - epetition response

published: 30 September 2008

Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study.

published: 24 September 2008

Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia.

published: 24 September 2008

Long term outcome of late chronic phase CML patients : GIMEMA Working Party on CML

published: 24 September 2008

Comparison between CML patients with CCR within 1yr and those achieving CCR after 12 months

published: 24 September 2008

GVHD reversed by extracorporeal photopheresis-treated cells (ECP)

published: 8 September 2008

RCF report on Postcode Lottery for Cancer treatment!

published: 4 September 2008

Monitoring and Adherence in CML- Webcast

published: 26 August 2008

CML Patient Groups call for improved access to cancer treatment

published: 18 August 2008

A postcode lottery in cancer care-

published: 11 August 2008

Read the Report on the second Parliamentary Summit on Rare Cancers

published: 1 August 2008

Applying for NHS Exceptional Funding for Treatment -

published: 1 August 2008

How complete is “complete” molecular response in imatinib-treated chronic myeloid leukemia?

published: 7 July 2008

Bone Marrow Donation Education Programme- Adrian's Petition

published: 26 May 2008

NHS spends almost 50% less on cancer drugs as some other EU countries

published: 23 May 2008